Call us for Counseling - 9580048004, For Support - 8860807050.  

Tags Current Affairs

COVID-19 patient without symptoms may have weaker immune response

Date: 20 June 2020 Tags: Miscellaneous


COVID-19 patients who do not show any symptoms of the disease may have a weaker immune response to the virus, according to a new study.



The research presents an analysis of the clinical and immunological manifestations of asymptomatic patients infected with the novel coronavirus, SARS-CoV-2.



  • It found that these patients had an average duration of viral shedding of 19 days, compared with 14 days in another group of 37 patients who showed symptoms of the disease.

  • Most people infected with SARS-CoV-2 experience a mild to severe respiratory illness with symptoms that include fever, cough, and shortness of breath that may appear 2-14 days after exposure.

  • They said several who test positive for the infection may either experience minor symptoms or be asymptomatic.

  • In comparison to symptomatic patients, the asymptomatic group had a significantly longer duration of viral shedding, with a viral shedding time of 19 days.

  • The levels of virus-specific immune system molecules called IgG antibodies were significantly lower in the asymptomatic group than in the symptomatic group during the acute phase of infection when the virus could be detected in the respiratory tract.

  • Eight weeks after the patients were discharged from the hospital, the levels of neutralising antibodies decreased in more than 8o per cent of asymptomatic patients, compared with about 62 per cent of symptomatic patients.

  • The IgG antibody levels in the patients also began to diminish within three months of infection in a large proportion of the asymptomatic patient.

  • This finding, along with previous analyses of neutralising antibodies in patients recovering from COVID-19, highlights the potential risks of using ‘immunity passports,’ and supports the continuation of public-health interventions and widespread testing.

  • They believe that further research in larger groups of symptomatic and asymptomatic patients is urgently needed to determine the duration of antibody-based immunity.

Notice (8): Undefined variable: quizpole [ROOT/plugins/Studyiq/src/Template/Pages/tagdetails.ctp, line 161]